Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative therapies work by mimicking the physiological actions of GLP-1, a hormone released by https://bookmarking1.com/story20791243/reta-glucagon-like-peptide-1-receptor-agonists